Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome
BACKGROUND: Cognitive decline has been reported after coronary artery revascularization, but whether it reflects procedure-specific effects or the burden of underlying vascular disease remains uncertain. OBJECTIVES: To determine whether incident dementia risk differs according to coronary revascularization strategy among older adults with acute coronary syndrome (ACS). METHODS: We conducted a longitudinal cohort study among adults aged ≥65 years hospitalized for ACS between 2010 and 2020 (n = 25,176). Patients underwent percutaneous coronary intervention (n = 8,043), coronary artery bypass grafting (n = 797), or received no revascularization (n = 16,336). A second comparator cohort included patients with stable coronary artery disease (CAD) without revascularization (n = 154,299). The primary outcome was incident dementia identified using validated International Classification of Diseases codes after a 1-year washout. Propensity-matched analyses used Cox models accounting for the competing risk of death. RESULTS: Revascularized patients were younger (74.8 ± 6.9 vs 77.1 ± 8.2 years), more often male (66.2% vs 54.0%), and had lower Elixhauser multimorbidity scores (4.6 ± 2.8 vs 5.4 ± 3.0, all P < 0.001). Over a median 4.8 years of follow-up, 9.0% of ACS patients developed dementia. Revascularization was not associated with increased dementia risk compared with ACS without revascularization (sub-hazard ratio: 1.05; 95% CI: 0.95-1.17) or stable CAD. Dementia risk was also similar between percutaneous coronary intervention and coronary artery bypass grafting. CONCLUSIONS: We found that among older adults with ACS, coronary revascularization was not statistically significantly associated with increased dementia risk compared with no revascularization or stable CAD. These findings reflect the hypothesis that the majority of dementia risk is potentially driven more by cumulative vascular and systemic factors than by procedure-specific neurotoxicity.
Authors
- Ashok Krishnaswami (ORCID: https://orcid.org/0000-0002-7892-0726)
- Deepak L. Bhatt (ORCID: https://orcid.org/0000-0002-1278-6245)
- Abdulla A. Damluji (ORCID: https://orcid.org/0000-0002-8774-6416)
- Annabelle Santos Volgman (ORCID: https://orcid.org/0000-0002-9918-0878)
- Ahmed Shah (ORCID: https://orcid.org/0000-0002-1719-3692)
- Howard Dinh
- Michelle M. Mielke
- Edward D. Shin
- Paola Gilsanz
- Neelum T. Aggarwal
- Amanda Jain
- Michael G. Nanna
- Janine Y. Yang
- Wynnelena Canio
- Richard Ha
- Mathew S. Maurer
Institutions
- Rush University Medical Center (US)
- Kaiser Permanente (US)
- Columbia University Irving Medical Center (US)
- Cleveland Foundation (US)
- Kaiser Permanente Oakland Medical Center (US)
- Yale University (US)
- Kaiser Permanente South Sacramento Medical Center (US)
- Mount Sinai Hospital (US)
- Kaiser Permanente San Rafael Medical Center (US)
- Kaiser Permanente Santa Clara Medical Center (US)
- Kaiser Permanente San Jose Medical Center (US)
- Wake Forest University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-08-28
- DOI
- https://doi.org/10.1016/j.jacadv.2026.103192
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kaiser Permanente